New investment helps to ensure patients can access high-quality and reproducible testing across labs worldwide NEW YORK, June 2, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced an investment of up to $2M to expand a quality control program for blood...
Read More Details
Finally We wish PressBee provided you with enough information of ( The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers )
Also on site :
- PBOC sets USD/ CNY central rate at 7.1886 (vs. estimate at 7.1977)
- ‘American Pickers' Mike Wolfe Makes a Bold Declaration About Country Star
- Structure Fire In Standard